Samanta T, Park J, Kaipparettu B
Cancers (Basel). 2025; 17(5).
PMID: 40075691
PMC: 11898429.
DOI: 10.3390/cancers17050844.
Gong T, Jiang J, Uthayopas K, Bornman M, Gheybi K, Stricker P
Nat Commun. 2025; 16(1):2400.
PMID: 40064858
PMC: 11893795.
DOI: 10.1038/s41467-025-57312-9.
Xu Y, Lai Z, Li C
Front Genet. 2025; 16:1536620.
PMID: 40051704
PMC: 11882561.
DOI: 10.3389/fgene.2025.1536620.
Jiang Y, Xu Y, He J, Sui L, Li T, Xia N
Front Pharmacol. 2025; 16:1525733.
PMID: 40046734
PMC: 11880013.
DOI: 10.3389/fphar.2025.1525733.
Ma Y, Boycott C, Zhang J, Gomilar R, Yang T, Stefanska B
Epigenetics. 2025; 20(1):2473770.
PMID: 40029260
PMC: 11881848.
DOI: 10.1080/15592294.2025.2473770.
A pan-cancer analysis of the oncogenic and immunological roles of RGS5 in clear cell renal cell carcinomas based on in vitro experiment validation.
Zhang Y, Wang H, Dai F, He K, Tuo Z, Wang J
Hum Genomics. 2025; 19(1):14.
PMID: 39985100
PMC: 11846387.
DOI: 10.1186/s40246-025-00717-w.
Cooperative nutrient scavenging is an evolutionary advantage in cancer.
Guzelsoy G, Elorza S, Ros M, Schachtner L, Hayashi M, Hobson-Gutierrez S
Nature. 2025; .
PMID: 39972131
DOI: 10.1038/s41586-025-08588-w.
Comprehensive exploration of signal sequence receptor subunit 1 (SSR1) as a diagnostic and prognostic biomarker in liver hepatocellular carcinoma.
Feng B, Chen W, Sun M, Ma X, Cao J, Zhang Z
Am J Transl Res. 2025; 17(1):560-584.
PMID: 39959210
PMC: 11826213.
DOI: 10.62347/ANXV3598.
VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis.
Yang J, Lu X, Hao J, Li L, Ruan Y, An X
Nat Commun. 2025; 16(1):1160.
PMID: 39880844
PMC: 11779845.
DOI: 10.1038/s41467-025-56494-6.
Integrative Analysis of Radiation-Induced Senescence-Associated Secretory Phenotype Factors in Kidney Cancer Progression.
Suman S
Genes (Basel). 2025; 16(1).
PMID: 39858632
PMC: 11765417.
DOI: 10.3390/genes16010085.
Unveiling as a Novel Prognostic Biomarker for Prostate Cancer Recurrence: From Gene to Prognosis.
Chang C, Chen L, Chen Y, Huang C, Yu C, Lin V
Biomedicines. 2025; 13(1).
PMID: 39857609
PMC: 11760481.
DOI: 10.3390/biomedicines13010025.
Col1A1 as a new decoder of clinical features and immune microenvironment in ovarian cancer.
Xiao X, Long F, Yu S, Wu W, Nie D, Ren X
Front Immunol. 2025; 15():1496090.
PMID: 39845977
PMC: 11750837.
DOI: 10.3389/fimmu.2024.1496090.
Uncovering the Role of in Prostate Cancer: Insights from Genetic and Expression Analyses.
Chang C, Bao B, Lu T, Chen L, Chen Y, Lin T
J Cancer. 2025; 16(3):932-941.
PMID: 39781359
PMC: 11705053.
DOI: 10.7150/jca.104705.
Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway.
Zhao G, Zhao X, Liu Z, Wang B, Dong P, Watari H
Sci Rep. 2025; 15(1):917.
PMID: 39762448
PMC: 11704301.
DOI: 10.1038/s41598-025-85466-5.
Nuclear Control of Mitochondrial Homeostasis and Venetoclax Efficacy in AML via COX4I1.
Zhang L, Zhang H, Wang T, Li M, Chan A, Kang H
Adv Sci (Weinh). 2024; 12(6):e2404620.
PMID: 39716856
PMC: 11809339.
DOI: 10.1002/advs.202404620.
A Prospective Tumour Marker for Breast Cancer: YWHAB and Its Role in Promoting Oncogenic Phenotypes.
Gopaul V, Winstone L, Gatien B, Nault B, Maiti S, Opperman R
Breast Cancer (Dove Med Press). 2024; 16:935-956.
PMID: 39703345
PMC: 11656333.
DOI: 10.2147/BCTT.S479384.
Hypoglycemic Agents Increase Regulatory Factor X1 to Inhibit Cancer Cell Behaviour in Human Glioblastoma Cells.
Shan W, Zuo K, Zuo Z
J Cell Mol Med. 2024; 28(23):e70260.
PMID: 39636301
PMC: 11619449.
DOI: 10.1111/jcmm.70260.
Nuclear Expression of Dynamin 2 Is Associated With Tumor Aggressiveness in Bladder Cancer Patients: A Bioinformatics and Experimental Approach.
Razmi M, Saeednejad Zanjani L, Rahimi M, Sajed R, Safaei S, Madjd Z
Cancer Rep (Hoboken). 2024; 7(12):e2133.
PMID: 39610009
PMC: 11604598.
DOI: 10.1002/cnr2.2133.
Importance of LINC00852/miR-145-5p in breast cancer: a bioinformatics and experimental study.
Shakoori A, Hosseinzadeh A, Nafisi N, Omranipour R, Sahebi L, Nazanin Hosseinkhan
Discov Oncol. 2024; 15(1):672.
PMID: 39557729
PMC: 11574217.
DOI: 10.1007/s12672-024-01553-5.
Pan-cancer analysis of STAT3 indicates its potential prognostic value and correlation with immune cell infiltration in prostate cancer.
Tuo Z, Zhang H, He K, Jiang Z, Jiang C, Chen X
Discov Oncol. 2024; 15(1):654.
PMID: 39541053
PMC: 11564492.
DOI: 10.1007/s12672-024-01527-7.